298 results on '"Kuerer H"'
Search Results
2. Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins
3. Six-Year Analysis of Treatment-Related Toxicities in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial
4. Burnout and Career Satisfaction Among Surgical Oncologists Compared with Other Surgical Specialties
5. Which threshold for ER positivity? a retrospective study based on 9639 patients
6. Local Control, Toxicity, and Cosmesis in Women Younger Than 50 Enrolled Onto the American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial
7. Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
8. Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab
9. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer
10. Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
11. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer
12. Emerging insights in the usage of ancillary molecular tests with nipple aspirate fluid cytology: O028
13. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: Results of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial
14. FOAM CELLS IN NIPPLE ASPIRATION FLUID
15. Abstract P3-01-05: Circulating tumor cell detection predicts early recurrence in patients with non-metastatic breast cancer
16. Abstract PD3-07: A phase II pre-surgical trial of lapatinib for the treatment of women with HER2 positive or EGFR positive ductal carcinoma in situ
17. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients
18. Using NCDB for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer
19. Breast conservation therapy in T4 locally advanced breast cancer: Effective local control with long-term survival
20. Baseline factors predicting a response to neoadjuvant chemotherapy with implications for non-surgical management of triple-negative breast cancer
21. The rate of immediate reconstruction following mastectomy for breast cancer varies by patient race
22. Sentinel lymph node biopsy accurately reflects nodal status following preoperative chemotherapy for breast cancer
23. Contralateral prophylactic mastectomy: Efficacy and determinants of significant histologic findings
24. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to the selective carcinoma in situ
25. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study
26. Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
27. LOP09
28. Quantification of Adipocyte Area at Invasive Breast Tumor Margins and in Benign Stroma
29. Abstract P5-13-03: Factors associated with prophylactic mastectomy among BRCA-positive patients with no personal history of breast cancer
30. Quantitative Analysis of Morphology Associated with Progression from Non-proliferative and Hyperplastic Ducts to Ductal Carcinoma in Situ in Human Breast Tissue
31. Low-risk Breast Ductal Carcinoma In Situ (DCIS): Results From the Radiation Therapy Oncology Group 9804 Phase 3 Trial
32. 895 Assessment of HER2 Status on Disseminated Tumor Cells in Early Stage Breast Cancer Using a Microfluidic Cell Enrichment and Extraction Technique
33. 1176 Biologic Features and Prognosis of Ductal Carcinoma in Situ Are Not Adversely Impacted by Large Body Mass
34. 802 Circulating Tumor Cells After Neoadjuvant Chemotherapy Predict Survival in Non-metastatic Breast Cancer
35. Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: A meta-analysis of 2 randomized trials
36. P4-07-11: Circulating Tumor Cells after Neoadjuvant Therapy Predict Outcome in Stage I to III Breast Cancer.
37. P5-01-17: HER2 Amplification in Primary Tumor: A Potential Marker for Presence of Circulating Tumor Cells in Inflammatory Breast Cancer Patients?
38. P4-06-02: Microscopic Disease in Blood and Bone Marrow Predicts Survival in Early Stage Breast Cancer.
39. P4-10-06: Evaluation of BRCAPro Risk Assessment Model in Patients with Ductal Carcinoma In Situ.
40. P4-07-07: Circulating Tumor Cells Predict Survival in Non-Metastatic Breast Cancer.
41. Six-Year Analysis of Treatment-Related Toxicities in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial
42. Impact of chemotherapy timing on local-regional failures in patients with breast cancer undergoing breast-conserving therapy.
43. A novel staging system for disease-specific survival in patients with breast cancer treated with surgery as the first intervention.
44. Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer.
45. An evaluation of bone marrow stromal-derived growth factor-1 and interleukin-8 levels in patients with stage I-III breast cancer with disseminated tumor cells.
46. Use of HER2 amplification in the primary tumor to predict presence of circulating tumor cells in inflammatory breast cancer.
47. A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up.
48. Detection of HER2 status of circulating tumor cells and disseminated tumor cells using a microfluidic platform (cell enrichment and extraction technology [CEE]).
49. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.
50. Circulating And Disseminated Tumor Cells After Neoadjuvant Therapy In Primary Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.